secwatch.observer — SEC 8-K summary
======================================

Issuer:     PALVELLA THERAPEUTICS, INC. (PVLA)
CIK:        0001583648
Form:       8-K
Filed at:   2026-01-12T23:59:59+00:00
Accession:  0001193125-26-009724
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Palvella posts corporate presentation; no new disclosures
---------------------------------------------------------

- Corporate presentation posted on company website on January 12, 2026.
- Presentation title: "First-in-disease therapies for patients with rare diseases."
- Company will use the presentation in investor meetings; no financial or pipeline updates in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1583648/000119312526009724/0001193125-26-009724-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1583648/000119312526009724/pvla-20260112.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-009724

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer